At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AMLX Amylyx Pharmaceuticals
Market Closed 07-31 16:00:00 EDT
20.31
-0.44
-2.12%
盘后20.31
+0.000.00%
19:34 EDT
High20.87Low19.30Vol1.83M
Open20.74D1 Closing20.75Amplitude7.59%
Mkt Cap2.26BTradable Cap1.91BTotal Shares111.19M
T/O36.74MT/O Rate1.95%Tradable Shares94.10M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

TAKAOKA TOKO Sets Out FY2026 Q1 Financial Overview for Its Energy Network Business
TIPRANKS  ·  07-30 13:52
TAKAOKA TOKO Sets Out FY2026 Q1 Financial Overview for Its Energy Network Business
Fuel costs on the rise as latest geopolitical turmoil drives up crude oil prices
Bloomberg  ·  07-24
Fuel costs on the rise as latest geopolitical turmoil drives up crude oil prices
Goldman Sachs Eyes $120 Oil Spike if Middle East Shipping Risks Continue
TIPRANKS  ·  07-21
Goldman Sachs Eyes $120 Oil Spike if Middle East Shipping Risks Continue
Hengyi Petrochemical Notes Product Prices Follow Crude Oil, But Profits Depend on Spreads
Deep News  ·  07-20
Hengyi Petrochemical Notes Product Prices Follow Crude Oil, But Profits Depend on Spreads
Trade Alert: Chief Legal Officer & General Counsel Of Amylyx Pharmaceuticals Gina Mazzariello Has Sold Stock
Simply Wall St.  ·  07-15
Trade Alert: Chief Legal Officer & General Counsel Of Amylyx Pharmaceuticals Gina Mazzariello Has Sold Stock
Amylyx Chief Legal Officer Gina Mazzariello Sells USD 539,362 of Common Stock
Reuters  ·  07-14
Amylyx Chief Legal Officer Gina Mazzariello Sells USD 539,362 of Common Stock
Kodiak Gas Services, Baker Hughes Announce Multi-Year Gas Turbine Order Agreement to Support U.S. Data Center Growth
GlobeNewswire  ·  07-08
Kodiak Gas Services, Baker Hughes Announce Multi-Year Gas Turbine Order Agreement to Support U.S. Data Center Growth
Analysts Are Bullish on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Guardian Pharmacy Services, Inc. Class A (GRDN)
TIPRANKS  ·  07-02
Analysts Are Bullish on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Guardian Pharmacy Services, Inc. Class A (GRDN)
Could Amylyx (AMLX) ALS Safety Data Quietly Reframe Its Neurodegeneration Versus Endocrine Strategy?
Simply Wall St.  ·  06-27
Could Amylyx (AMLX) ALS Safety Data Quietly Reframe Its Neurodegeneration Versus Endocrine Strategy?
Amylyx Pharmaceuticals is Maintained at Buy by Guggenheim
Dow Jones  ·  06-25
Amylyx Pharmaceuticals is Maintained at Buy by Guggenheim
Amylyx reports clean safety in lowest-dose cohort of Phase 1 LUMINA trial of ALS drug AMX0114
Reuters  ·  06-23
Amylyx reports clean safety in lowest-dose cohort of Phase 1 LUMINA trial of ALS drug AMX0114
Amylyx Pharmaceuticals to Present Data From First-in-Human, Dose-Ranging Phase 1 Lumina Trial of Amx0114 in ALS at Encals 2026
THOMSON REUTERS  ·  06-23
Amylyx Pharmaceuticals to Present Data From First-in-Human, Dose-Ranging Phase 1 Lumina Trial of Amx0114 in ALS at Encals 2026
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Amylyx Pharmaceuticals Inc (AMLX) and AbCellera Biologics (ABCL)
TIPRANKS  ·  06-18
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Amylyx Pharmaceuticals Inc (AMLX) and AbCellera Biologics (ABCL)
Analysts’ Top Healthcare Picks: Amylyx Pharmaceuticals Inc (AMLX), Ascendis Pharma (ASND)
TIPRANKS  ·  06-16
Analysts’ Top Healthcare Picks: Amylyx Pharmaceuticals Inc (AMLX), Ascendis Pharma (ASND)
Amylyx to present avexitide Phase 3 LUCIDITY trial design poster at ENDO 2026
Reuters  ·  06-08
Amylyx to present avexitide Phase 3 LUCIDITY trial design poster at ENDO 2026
Amylyx Pharmaceuticals shareholders elect Milne, Fonteyne as Class II directors
Reuters  ·  06-05
Amylyx Pharmaceuticals shareholders elect Milne, Fonteyne as Class II directors
HELIOS Wolfram Data And Patient Insights Could Be A Game Changer For Amylyx Pharmaceuticals (AMLX)
Simply Wall St.  ·  05-29
HELIOS Wolfram Data And Patient Insights Could Be A Game Changer For Amylyx Pharmaceuticals (AMLX)
Amylyx director Karen Firestone acquires $51,338 of common shares
Reuters  ·  05-27
Amylyx director Karen Firestone acquires $51,338 of common shares
Do HELIOS Data Shift Amylyx (AMLX) From ALS Setback To Broader Rare-Disease Strategy Reboot?
Simply Wall St.  ·  05-22
Do HELIOS Data Shift Amylyx (AMLX) From ALS Setback To Broader Rare-Disease Strategy Reboot?
Amylyx announces publication of Phase 2 open-label HELIOS trial data
TIPRANKS  ·  05-16
Amylyx announces publication of Phase 2 open-label HELIOS trial data

Introduction

Company Name.
Amylyx Pharmaceuticals
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Issue price:
--